Faculty & Scientific Staff

Jerry Nepom

Gerald Nepom, MD, PhD

Emeritus Member, Center for Interventional Immunology; ITN Senior Advisor
Immune Tolerance Network

Background Information

Dr. Nepom received his bachelor’s degree in Biochemistry from Harvard in 1972 and doctorates from the University of Washington, receiving his PhD in Biochemistry in 1977 and his MD in 1978. After post-doctoral work in immunogenetics in the Department of Pathology at Harvard Medical School, he returned to Seattle, joining the Fred Hutchinson Cancer Research Center and the University of Washington Medical School Faculty in 1982. Since 1985 he has been a Member of the Benaroya Research Institute at Virginia Mason (BRI) and served as Director of BRI from 1985 through 2015. Dr. Nepom also served as Director of the Immune Tolerance Network (ITN), sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) from 2010 to 2022. He is currently an Emeritus Faculty Member of BRI and Senior Advisor to ITN.

Area Of Research

Dr. Nepom's interests are focused on identifying and understanding molecular and genetic mechanisms contributing to pathogenesis of autoimmune disorders and using this information to evaluate autoreactive T cell lineage and fate determination. Translational and clinical applications include development and use of immunological monitoring tools for predicting disease susceptibility and response to therapy in clinical trials, with special emphasis on type 1 diabetes.

Related Stories

Blog Main Image - Peanut Butter in Jar Top View
April 11, 2022

Progress Against Peanut Allergies

One question inspired Erik Wambre, PhD, to dedicate his career to allergy research. “Why can most people eat peanuts without a problem, but some people have a serious reaction to just a small amount?” he says. “What makes one person allergic and not another?”

Read Article
Blog Main Image - EDITORIAL Debra Smith Sofia Smith
June 15, 2021

Hope for MS Powers Support for BRI

Debra Smith first learned about BRI when a friend invited her to the Boeing Classic Golf Tournament in the early 2010s. BRI’s work became personal when she was diagnosed with multiple sclerosis (MS) in 2013.

Read Article
Blog Main Image - 3D COVID Syringes
December 21, 2020

Volunteering in a COVID-19 Vaccine Trial: BRI Team Members Share Their Experience

Without clinical research participants, we might not have groundbreaking cancer treatments like immunotherapy or vaccines for polio, rubella and other life-threatening diseases.

Read Article


News Immune Tolerance Network ITN

Benaroya Research Institute at Virginia Mason Receives Second 7-Year Award from the National Institutes of Health to Lead the Immune Tolerance Network

Read More

Biological 'atlas' shows dual personality for immune cells that cause type 1 diabetes

Read more ➡
Science in Seattle Logo

A New Clinical Trial on the Treatment of Multiple Sclerosis Starts Enrollment

Read news ➡